Researchers found specific red blood cell manufacturing methods cause less damage than others, potentially improving transfusion outcomes. The study debunks the long-held belief that storage duration affects DAMPs, instead linking levels to manufacturing processes.
A study published in Blood journal reveals that individuals with rare blood type Pk are more resistant to HIV infection, while those without it are more susceptible. This discovery paves the way for new therapeutic approaches to induce HIV resistance and promote further understanding of the pandemic.
A Canadian Blood Services scientist has developed a potential alternative to costly IVIg treatment, which could lead to more effective and safer therapies for patients with life-threatening illnesses. The synthetic product could also reduce production costs and increase availability.